Alopecia Market 2030 - A Look at What's Available and What's Coming Soon
The global alopecia market is projected to reach a staggering USD 16.02 billion by 2030, reflecting a robust CAGR of 9.1% from 2024 to 2030. This growth is fueled by several key factors, including the approval of innovative medications and a surge in public awareness about alopecia. One significant driver is the emergence of targeted pharmaceutical therapies. The U.S. FDA's approval of Lilly's Olumiant in June 2022 marked a turning point, introducing the first systemic treatment for severe alopecia in adults. Similarly, Pfizer's Ritlecitinib, a promising dual inhibitor, is anticipated for approval in 2023, further bolstering the treatment landscape. Another critical factor propelling the market is the rising awareness of alopecia. This heightened consciousness regarding physical appearance translates to an increased number of individuals seeking treatment for hair loss. Additionally, growing investments in research and development (R&D) efforts hold immense promise f...